Trading the Dilution Cycle: Pre-Offering Runs and Post-ATM Fades (+776.2%)

TLDR

• Over the last five sessions (last week, July 14–17, into Monday July 20), eight small caps ran 50% or more close-to-close. ZYBT led at +776.2% ($0.70 → $6.15) on 165.7M shares — the textbook pre-offering run.
• The dilution cycle has two tradable edges: the pre-offering run, where market makers and insiders push price higher before an offering prices, and the post-ATM fade, where registered shares hit the tape and the stock bleeds. ZYBT printed both in one Monday — a full-day high of $11.40, a regular-session close of $6.15, then $3.52 after-hours.
• Featured runners: ZYBT (+776.2%), GORO (+147.3%), CPHI (+80.6%), ADVB (+71.0%), CJMB (+64.4%). CPHI ran +84.4% on July 15 with 3–6 months of cash runway and a filing stating the company knew of no events behind the move — the classic dilution-risk profile.
• Last week was runner-heavy: 20 stocks cleared +50% versus a 4-week baseline near 8. Scanner pattern volume (137 patterns) ran roughly 23% below the 90-day weekly average of 178 — fewer setups, bigger payoffs.
• Small caps are leading: Russell 2000 (IWM) at $292.31 sits within 5% of its 52-week high while Nasdaq 100 (QQQ) is 7.0% off its high. When small caps lead, these squeezes follow through.

What Is the Dilution Cycle Pattern?

The dilution cycle is the repeatable price arc a cash-hungry small cap traces around a capital raise: an accumulation phase, a volume-driven run, an offering that prices into that strength, and a fade as newly registered shares get sold into the market. It is one pattern with two distinct trades on opposite sides of the same event.

The pre-offering run comes first. A company with a live shelf or ATM program needs shares to price as high as possible — a $10M raise costs far fewer shares at $6 than at $1. That incentive shows up as liquidity tests, where market makers probe supply and demand at key levels, followed by a volume expansion that lifts the stock. This is the accumulation-into-strength leg, and it is where the fast money makes its money on the long side.

The post-ATM fade comes second. Once an offering prices — a 424B5 pricing supplement, an at-the-market takedown, or a private placement — the registered stock becomes real supply. Bids get absorbed, the run stalls, and the chart rolls over. That is the short/exit leg. If you have read Short Squeeze Mechanics: The Float Rotation Behind FCUV's +239.4% MFE, this is the mirror image: the same float mechanics that fuel a squeeze become the anchor that ends it once new shares register.

One distinction traders miss: active facilities are a threat, completed offerings are history. A convertible note shown fully converted with $0 remaining already diluted — it is not overhang. A shelf that is registered but undrawn is capacity, not supply. Read the status before you assume the fade is coming.

Last Week's Dilution-Cycle Runners (July 14–20)

Eight small caps posted a split-adjusted close-to-close gain of 50% or more over the last five sessions, and the five featured below all carry the volume and structure that define the pre-offering run. ZYBT's 165.7M-share, +776.2% move was the standout; CPHI's +80.6% on 94.1M total shares came with a cash profile that makes the dilution cycle almost a template.

Sector rotation lines up with the leaderboard. Healthcare RVOL jumped from 0.85 to 4.05 week-over-week (+377%), which is where both ZYBT and ADVB sit. Pharmaceuticals climbed from 1.91 to 3.03 (+59%), CPHI's sector. Capital is rotating into exactly the corners where these runs printed — a tell you can watch in real time.

Context for scale: last week the tape flagged 137 patterns overall, about 23% below the 90-day weekly average of 178. Fewer setups fired, but the ones that did paid: 16 stocks traded 100M-plus shares, 72 liquidity tests printed, and 49 stocks doubled from their intraday low — all 49 reached their targets. Twenty stocks cleared +50% for the week against a four-week baseline near eight, more than double the normal runner count.

ZYBT: Anatomy of a Pre-Offering Run and the After-Hours Fade

ZYBT is the cleanest full-cycle example on the board: it ran the entire arc in one session. Over five sessions it went $0.70 → $6.15 for +776.2%, and on Monday July 20 it opened the regular session at $1.27, printed a full-day high of $11.40, closed the regular session at $6.15 (+384.2% on the day), then faded to $3.52 after-hours. The specific catalyst was not identified in available press releases — this was a volume-and-structure move, not a news move.

The pre-signals were all on the scanner before the blow-off. Volume expanded to 165.7M shares at 1,387.5x its 50-day average — a stock that normally trades thin suddenly carrying nine figures of turnover is the single loudest tell. Healthcare was the top-rotating sector at +377% RVOL week-over-week. And ZYBT had already qualified as a multi-day runner by mid-week, meaning it showed up on a continuation scan a full session or two before Monday's climax. None of that requires guessing the catalyst — you are trading the mechanics, exactly the framework laid out in What Is AI Trading Pattern Detection? A Trader's Reference Guide.

Here is the part traders need to internalize: the $11.40 print was the trap, not the target. From the full-day high to the regular-session close of $6.15, the stock gave back roughly 46%. From $11.40 to the $3.52 after-hours close, it shed about 69%. The pre-offering run and the fade lived inside the same twelve-hour window. A trader long from the volume expansion captured a life-changing move; a trader who chased the vertical spike into $11.40 was underwater by the close.

Winners and Losers: The Fade Is the Other Half of the Trade

Every pre-offering run has a losing trade baked into it, and it is almost always the chase into the climax high. CPHI is the honest lesson. On July 15, CPHI opened the regular session at $0.60, ran to a full-day high of $1.60 (+84.4% on the day), then bled to a $1.10 regular-session close and $1.03 after-hours. Its max favorable excursion was +184.7% low-to-high, from $0.56 to $1.60 on 81.6M shares — a real, catchable window for anyone positioned early.

Now the loser. A trader who bought the $1.60 high — the emotional "it's going to $3" entry — closed the regular session at $1.10, down about 31%, and worse into the $1.03 after-hours print. Same stock, same day, and the difference between +184.7% and −31% was nothing but where on the curve you entered. CPHI's profile is why this pattern rewards discipline: 3–6 months of cash runway plus a filing that explicitly stated the company "knows of no events that could have caused unusual market activity" is the textbook dilution-risk setup. A low-cash name that runs 80%-plus with no announced reason is the exact candidate that prices an offering into the spike.

The framework rule that falls out of both ZYBT and CPHI: the offering print and the after-hours session are where the pre-offering run goes to die. ZYBT faded $6.15 → $3.52 after hours; CPHI faded $1.60 → $1.03. Holding a low-cash runner through the close and into extended hours is holding it into the exact window where new supply is most likely to hit.

The Current Dilution Pipeline: What's Filing Now

The offering side of the cycle is filing in real time, and the counts are exact — no estimation. In the past three days the tape logged 8 424B3 prospectus supplements from 5 unique tickers, 2 424B5 pricing supplements, 2 fresh S-3 shelf registrations, 1 S-3/A amendment, 2 F-3 foreign-issuer shelves, and 3 S-1/A amendments. Alongside that, 106 8-K filings landed across 104 unique tickers — the event stream where offerings, closings, and material developments surface first.

Zoom out and the standing dilution capacity across the small-cap universe is enormous (approximate counts; exact totals withheld): roughly ~5,700 active warrant facilities, ~3,000 active shelves, ~2,000 active ATM programs, ~1,400 convertible notes, ~800 convertible preferred, ~600 S-1 offerings, and ~500 equity lines. That is the fuel supply for the fade side of every cycle. The job is not to fear it — it is to know which stage of the cycle a given ticker is in, and the SEC research dilution snapshot answers that directly: active facility counts, shares at risk, and lowest exercise price on one screen.

Entry and Exit Framework

The framework tracks the two legs of the cycle rather than a single entry. This is structure-level guidance, not financial advice — you build the rules, the scanner surfaces the candidates.

• Where to look for the long (pre-offering run): the first real volume expansion — a thin name suddenly carrying 100M-plus shares or extreme RVOL — after an early liquidity test that probed and held a key level. ZYBT was carrying 1,387.5x ADV; CPHI was in a Pharmaceuticals sector rotating in at +59% RVOL. Rotation plus volume is the confirmation.
• Where the risk lives: the vertical climax print. On ZYBT that was $11.40; on CPHI that was $1.60. Chasing the last leg of a parabola is the losing trade in this entire pattern. Structure a stop beneath the reclaimed level or session VWAP, not beneath the climax high.
• Targets: prior high-of-day, then a measured move off the base. On the featured runners the profit lived in the middle of the move, not at the apex.
• The fade rule: low-cash runners with active ATM/shelf capacity historically give back the gain into the close and after-hours. ZYBT faded $6.15 → $3.52; CPHI faded $1.60 → $1.03. Treat the offering print and extended hours as the exit window, not the add window.

One more discipline layer: log every one of these in your trading journal with the setup tag and the entry-on-the-curve. The AI Insights engine reads your fills back and shows your actual MFE capture rate — whether you are the trader who caught the $0.56-to-$1.60 window or the one who keeps buying the $1.60 print.

How to Set Up This Scan on SNACS

The fastest way to catch a pre-offering run before the climax is a two-filter volume-and-structure scan on the SNACS scanner. Set RVOL to 5x minimum, price $0.50–$20, and add a volume floor around 10M so thin names are excluded; sort by RVOL descending so the highest relative-volume tickers surface first. That single view would have put ZYBT and CPHI at the top of the stream on their run days.

From there, layer in the dilution read. Click any ticker to open the ticker details drawer — chart, recent news, SEC filings, and the dilution risk panel showing active shelf, ATM, and warrant facilities, all without leaving the scanner. The scanner's Dilution Alerts column and the SEC research dilution snapshot give you two paths to the same answer: is this a stock with the capacity to price an offering into the run? CPHI's 3–6 month runway is exactly the flag you want lit.

To make it repeatable, save the filter as a named preset and link it to a Dynamic Watchlist — the scan results auto-populate the watchlist in real time, so matched tickers carry a colored square in the main stream the moment they qualify. Then build the entry trigger in the AI Playbook Builder: a multi-step setup that fires a star indicator on the scanner when a ticker completes your historical-context → volume-expansion → trigger sequence, with alerts routed in-app, email, or SMS. For the mechanics behind why the run and the fade both trace to the share count, Float Rotation Explained: When Volume Exceeds the Float is the companion read.

What to Watch Next

With Small-Cap Leadership intact — Russell 2000 (IWM) at $292.31 within 5% of its 52-week high while Nasdaq 100 (QQQ) sits 7.0% off — the tape stays friendly to these squeezes. The last four Tuesdays have averaged an 85.5% top gain, and this week's Redis stream showed no significant pre-market activity as of 8:15 AM ET, meaning the setups are still coiling rather than firing. Watch Healthcare and Pharmaceuticals for the next candidate, keep the SEC filing pipeline open for the 424B5 prints that mark the fade, and let the scanner surface the volume expansion before you commit. The edge is not predicting the catalyst — it is being early to the volume and disciplined into the offering.

FAQ

What is the dilution cycle in small-cap trading?

The dilution cycle is the repeatable price arc a cash-hungry small cap traces around a capital raise: accumulation, a volume-driven pre-offering run, the offering pricing into that strength, then a post-offering fade as newly registered shares get sold. It contains two separate trades — a long on the run and a short/exit on the fade — around the same event.

How do you spot a pre-offering run before it climaxes?

Watch for a thin stock suddenly carrying 100M-plus shares or extreme RVOL after an early liquidity test holds a key level. ZYBT was trading 1,387.5x its 50-day average volume and its Healthcare sector was rotating in at +377% RVOL before Monday's +776.2% run. Volume expansion plus sector rotation is the confirmation, and neither requires knowing the catalyst.

Why do low-cash small caps run up before diluting?

Because the company and its market makers want to price shares as high as possible — a fixed-dollar raise costs far fewer shares at $6 than at $1. That incentive pushes price up ahead of an offering. CPHI, with 3–6 months of cash runway, ran +84.4% on July 15 with a filing stating it knew of no events behind the move — the textbook low-cash-runner-into-a-raise profile.

What is MFE and why does it matter here?

MFE (max favorable excursion) is the best possible trade from the day's low to its high across all sessions. It matters because a stock can close red yet still have offered a huge window: CPHI's MFE was +184.7% ($0.56 to $1.60) even though it closed the day at $1.10. The number tells you the real opportunity that existed, independent of the closing print.

Where is the biggest risk in trading the dilution cycle?

The biggest risk is chasing the vertical climax print. ZYBT's full-day high was $11.40 but its regular-session close was $6.15 — a ~46% giveback — and it faded to $3.52 after-hours. CPHI's high was $1.60 versus an $1.10 close. The offering print and the after-hours session are where these runs typically die, so holding low-cash runners into the close carries the most supply risk.

How do I check a stock's dilution capacity on SNACS?

Click any ticker to open the ticker details drawer, which shows the dilution risk panel with active shelf, ATM, and warrant facility counts. The SEC research dilution snapshot gives the same read in more depth — active facilities, shares at risk, and lowest exercise price — so you can tell whether a stock is a run candidate or already past its offering.

What scanner filters find these setups fastest?

Set RVOL to 5x minimum, price $0.50–$20, a volume floor near 10M to drop thin names, and sort by RVOL descending. Add the Dilution Alerts column to flag names with active facilities. Save the combination as a preset and link it to a Dynamic Watchlist so qualifying tickers auto-populate and show a colored square in the live stream.

How does an ATM offering differ from a 424B5 for the fade trade?

An ATM (at-the-market) program sells shares gradually into the open market at prevailing prices, so its supply pressure is steady and drawn out. A 424B5 is a priced shelf takedown — a specific dollar raise hitting at once — which tends to mark the sharpest post-offering fade. In the past three days, 2 companies filed 424B5 pricing supplements versus roughly ~2,000 active ATM programs standing across the universe.